Iloprost Inhalation Solution (Ventavis)

( DrugBank: Iloprost / KEGG DRUG: Iloprost )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	1

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00109681 (ClinicalTrials.gov)	April 2005	2/5/2005	Inhaled Iloprostin Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary ...	A Randomized, Double-blind, Placebo-Controlled Phase II Study to Evaluate the Safety and Pilot Effic ...	Pulmonary Fibrosis;Pulmonary Hypertension	Drug: Iloprost Inhalation Solution (Ventavis)	Actelion	NULL	Completed	40 Years	85 Years	Both	50	Phase 2	United States

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00453414 (ClinicalTrials.gov)	July 2006	27/3/2007	Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension	Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: Iloprost Inhalation Solution (Ventavis)	Actelion	NULL	Withdrawn	3 Years	18 Years	Both	0	Phase 2	United States